Intestine Bacteria and Breast Cancer Risk
NCT01461070 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175
Last updated 2020-05-27
Summary
Background:
\- Some bacteria found in the large and small intestines help keep people healthy and aid digestion. They may also affect a person s risk of developing cancer. Researchers want to study the relationship between intestinal bacteria and breast cancer risk factors. They can do this by looking at stool and urine samples from postmenopausal women.
Objectives:
\- To study intestinal bacteria and its relationship to urine-based markers of breast cancer risk in women.
Eligibility:
\- Women between 55 and 69 years of age with a recent mammogram that showed no signs of cancer.
Design:
* Participants will be screened with a medical history and basic health questionnaire.
* At home, participants will complete questionnaires about cancer risk factors and food consumption.
* Participants will also collect urine and stool samples. They will send the samples to the designated labs for study.
* No treatment will be provided as part of this protocol.
Conditions
- Breast Neoplasms
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Rashmi Sinha, Ph.D. · National Cancer Institute (NCI)
Eligibility
- Min Age
- 50 Years
- Max Age
- 69 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-10
- Primary Completion
- 2014-06-30
- Completion
- 2020-05-22
Countries
- United States
Study Locations
More Related Trials
-
Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study
NCT05444647 ·Status: UNKNOWN
-
Overall Diet Quality and Breast Cancer Risk
NCT03304171 ·Status: COMPLETED
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT07076147 ·Status: RECRUITING
-
Susceptibility to Breast Cancer
NCT00004565 ·Status: COMPLETED
-
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy
NCT06318507 ·Status: RECRUITING
-
Tumor Integrating Gut Microbiota in bREast Cancer
NCT07253168 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gut Microbe Composition, Exercise, and Breast Breast Cancer Survivors
NCT04088708 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Relationship Between Alterations in the GI Microbiome and GI Inflammation on Symptom Burden in Women With Breast Cancer Receiving Chemotherapy
NCT06238986 ·Status: TERMINATED
-
Effects of Fetal, Infant, and Early Childhood Exposures on Adult Cancer Risk in Women
NCT00559039 ·Status: COMPLETED
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach
NCT00393406 ·Status: COMPLETED
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer
NCT00989638 ·Status: ACTIVE_NOT_RECRUITING
-
Outcomes of Education and Counseling for BRCA1 Testing
NCT00001468 ·Status: COMPLETED
-
National Survey on Infiltrative Breast Cancer
NCT00696527 ·Status: COMPLETED
-
Relationship Between Gut Microbiome and Adjuvant Chemotherapy in Patients With Early Breast Cancer
NCT03702868 ·Status: TERMINATED
-
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105
NCT00959244 ·Status: COMPLETED
-
Study of Tumor and Blood Samples From Women With Breast Cancer
NCT00897728 ·Status: UNKNOWN
-
Triple Negative Breast Cancer: Identification Pilot Study of Predictive Transcriptome Profiles of Early Tumor Drug Resistance Observed in 18F-Fluorodeoxyglucose (FDG) PET
NCT02850302 ·Status: COMPLETED ·Phase: NA
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
NCT00006421 ·Status: COMPLETED
-
Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer
NCT00766454 ·Status: COMPLETED
-
Microbiome Immunotherapy Neoadjuvant Assessment
NCT06709651 ·Status: RECRUITING
-
Cancer Prevention in Women With a BRCA Mutation
NCT02225015 ·Status: UNKNOWN ·Phase: PHASE1
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer
NCT00276120 ·Status: COMPLETED